/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

D

Duncan Bellamy

University of Oxford(GB)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

54

Papers

12.2K

Citations

21

h-index

30

i10-index

Duncan Bellamy is an academic researcher from University of Oxford. The author has contributed to research in topics: Malaria Research and Control & Mosquito-borne diseases and control & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 21, co-authored 46 publications.

ORCID: 0000-0003-3614-0032

Research Topics

Malaria Research and Control Mosquito-borne diseases and control SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Influenza Virus Research Studies

Papers by this author

works

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

2021 · The Lancet · 1,200 citations

https://doi.org/10.1016/s0140-6736(21)00432-3

Merryn Voysey Sue Ann Costa Clemens Shabir A. Madhi Lily Yin Weckx

Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial

2022 · The Lancet Microbe · 26 citations

https://doi.org/10.1016/s2666-5247(22)00126-4

Daniel Jenkin Adam Ritchie Jeremy Aboagye Sofiya Fedosyuk

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18–45 years: an open-label, partially blinded, phase 1–2a controlled human malaria infection study

2025 · The Lancet Microbe · 11 citations

https://doi.org/10.1016/s2666-5247(24)00083-1

Navin Venkatraman Daniel Silman Duncan Bellamy Lisa Stockdale

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials

2025 · The Lancet Microbe · 10 citations

https://doi.org/10.1016/s2666-5247(24)00084-3

Navin Venkatraman Alfred B. Tiono Georgina Bowyer Duncan Bellamy

Research topics

topics

Malaria Research and Control

Mosquito-borne diseases and control

SARS-CoV-2 and COVID-19 Research

COVID-19 Clinical Research Studies

Influenza Virus Research Studies

Chat about Author

Papers

Chat

Click to start Chat